AspiAir GmbH
Gemünden (Wohra), DE · 1 known investors
AspiAir is a clinical-stage biotech company developing LASAG Inhale, an inhaled non-opioid treatment for pain and migraine attacks using acetylsalicylic acid. The company serves patients in the EU who lack access to adequate migraine medications and aims to provide a safe, mobile alternative to current therapies.
BiotechHealthtechMedical Devices
Founders & leadership
DS
Dr. Stefan DegenhardtManaging Director & CFO
DS
Dr. Sebastian CanisiusChief Medical Officer
DK
Dr. Karlheinz NockerProject Manager